Literature DB >> 3278711

Quantitative structure-activity relationships in amphotericin B derivatives.

M Chéron1, B Cybulska, J Mazerski, J Grzybowska, A Czerwiński, E Borowski.   

Abstract

The quantitative structure-activity relationships studies of amphotericin B and its 16 semisynthetic derivatives obtained by modification at carboxyl and amino groups have been done. The results of five biological tests were subjected to principal component analysis, a numerical method useful in the investigation of large sets of data. For some compounds, also, interaction with lipidic vesicles was investigated by spectroscopic methods. The results obtained indicate that: (i) The presence of positively charged nitrogen atom (protonable or bearing fixed charge) is indispensable for biological activity and antibiotic-sterol interaction; (ii) The lack of free carboxyl group in the molecule favours the differentiation between cholesterol and ergosterol containing cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278711     DOI: 10.1016/0006-2952(88)90168-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  28 in total

1.  Characterization of the unique function of a reduced amide bond in a cytolytic peptide that acts on phospholipid membranes.

Authors:  J E Oh; K H Lee
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity.

Authors:  Daniel S Palacios; Thomas M Anderson; Martin D Burke
Journal:  J Am Chem Soc       Date:  2007-10-23       Impact factor: 15.419

3.  The in vitro characterization of polyene glycosyltransferases AmphDI and NysDI.

Authors:  Changsheng Zhang; Rocco Moretti; Jiqing Jiang; Jon S Thorson
Journal:  Chembiochem       Date:  2008-10-13       Impact factor: 3.164

4.  Identification and characterization of the antimicrobial peptide corresponding to C-terminal beta-sheet domain of tenecin 1, an antibacterial protein of larvae of Tenebrio molitor.

Authors:  K H Lee; S Y Hong; J E Oh; M Kwon; J H Yoon; J Lee; B L Lee; H M Moon
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

Review 5.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  Influence of net charge on the aggregation and solubility behaviour of amphotericin B and its derivatives in aqueous media.

Authors:  J Mazerski; J Grzybowska; E Borowski
Journal:  Eur Biophys J       Date:  1990       Impact factor: 1.733

7.  In vitro antifungal activity and cytotoxicity of a novel membrane-active peptide.

Authors:  S Y Hong; J E Oh; K H Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

8.  Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.

Authors:  Joanna Boros-Majewska; Natalia Salewska; Edward Borowski; Sławomir Milewski; Sladjana Malic; Xiao-Qing Wei; Anthony J Hayes; Melanie J Wilson; David W Williams
Journal:  Med Microbiol Immunol       Date:  2014-06-13       Impact factor: 3.402

Review 9.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

10.  C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells.

Authors:  Brandon C Wilcock; Matthew M Endo; Brice E Uno; Martin D Burke
Journal:  J Am Chem Soc       Date:  2013-06-03       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.